TABLE 5.
PBP | IC50 (μg/ml) |
|||||||
---|---|---|---|---|---|---|---|---|
E. coli NIHJ JC-2 |
K. pneumoniae SR22291 |
P. aeruginosa ATCC 27853 |
A. baumannii ATCC 17978 a |
|||||
Cefiderocol | Ceftazidime | Cefiderocol | Ceftazidime | Cefiderocol | Ceftazidime | Cefiderocol | Ceftazidime | |
PBP1a | 3.80 | >4 | 2.80 | 1.50 | 0.85 | 3.62 | 1.05 | 0.91 |
PBP1b | 3.37 | >4 | 3.50 | 2.30 | >4 | >4 | ||
PBP2 | 2.12 | >4 | 0.063 | 0.41 | >4 | >4 | 2.31 | >64 |
PBP3 | 0.04 | 0.45 | 0.062 | 0.22 | 0.06 | 0.09 | 0.67 | 1.78 |
PBP4 | NCb | >1 | 0.28 | 3.60 | >4 | >4 | NDc | ND |
The IC50s cannot be divided into separate values for PBP1a and PBP1b.
NC, not calculated. Cefiderocol inhibited 63% of PBP4 at 4 μg/ml, but the sigmoid curve did not fit and the IC50 cannot be calculated.
ND, not detected.